MonoSol must face states’ Suboxone complaint
Just two weeks after dismissing Reckitt Benckiser Healthcare from an antitrust lawsuit alleging it monopolised the production of its opioid treatment drug Suboxone, a federal judge in Pennsylvania ruled that co-defendant MonoSol must face the claims.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10